Univadis COVID-19 Weekly Overview 15 May

  • Ben Gallarda
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Due to the rapidly changing nature of the COVID-19 pandemic, we at Univadis would like to share with you the most impactful and clinically relevant articles across our network from the past week.

Some of these articles are only published in local languages, but we have tried to summarize the key points for you below and link to the original source of each article in case you would like to read more, with languages other than English noted in brackets.

This is a snapshot of emerging best-practices during a rapidly evolving pandemic. Any and all information currently available related to COVID-19 is subject to change as more details become available. Some of the information below may also be contradicted by local or global health authorities. You can find all of the most up-to-date COVID-19 coverage on your local Univadis site or smartphone application.

We hope this information will be useful to your ongoing medical care for all patients, whether directly involved with COVID-19 or not.

  1. A new CRISPR-based diagnostic has been approved by the FDA, reporting high sensitivity and specificity and the potential for at-home use eventually.
  2. Recommendations for managing stroke have been published, focusing on treatment algorithms for 1) ER stroke patients with suspected COVID-19, 2) hospitalized COVID-19 patients who develop stroke, and 3) patients with stroke presenting at hospitals with limited resources due to COVID-19.
  3. The Italian Ministry of Health has released a statement [PDF - Italian] on the role of serological testing in managing the epidemic.
  4. Spanish AEMPS has issued warnings about non-approved self-diagnostic test which are being advertised online.
  5. Over 48,000 health professionals in Spain have tested positive for SARS-CoV-2, out of around 225,000 total cases. Spanish epidemiological surveillance [Spanish] reports that at least 35 have died.
  6. Behavioral experts have put forward 11 key communication principles for the UK Government to consider in order to clarify their messaging around the next phase of COVID-19 response. These emphasize clarity, positive messages, and acting together to manage the epidemic.
  7. Diabetes UK and the Association of British Clinical Diabetologists have released guidelines for managing diabetes in care homes. These focus on careful monitoring and attention to medication stocks and trends in patient signs and symptoms.
  8. Public Health France has set up a behavioral and psychological monitoring system to assess the psychological impact of containment. Results from two rounds of surveys show an initial doubling of anxiety, with a decrease in the second round. Disadvantaged populations were more negatively affected but more knowledge about the disease had a positive effect.
  9. New recommendations for managing pregnant women with COVID-19 are available from the ISIDOG. These cover risk management, impacts on outcomes, delivery method preferences, postpartum risks, and more.